Apellis Pharmaceuticals, Inc. (APLS) has a market capitalization of $5.22B and trades at $40.85. The 52-week range is 16.1-40.48.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 226.9, Earnings Per Share (EPS) of $0.18, annual revenue of $1B.
The stock has a beta of -0.20, operates in the Healthcare sector.
